HekeTiss SA is a spin-off from the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG) established in 2022.

Headquartered in the canton of Geneva, HekeTiss was founded by four innovative scientists with long-lasting experience in regeneration and immunity to pursue the production and commercialization of a novel and patented cell-based solution for treating chronic wounds.

Heketiss beneficiated from several international prizes and sponsors.